Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004836-61Phase 2Terminated
Phase 2, single-arm trial of dexmedetomidine in None, sponsored by Royal Hospital for Children. Primary endpoint: Acceptable sedation as determined by COMFORT scale. Started Oct 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004836-61.